Workup for Multiple Hepatic Cysts
Begin with ultrasound as your first-line imaging modality to diagnose multiple hepatic cysts, then characterize them by number (solitary vs. multiple) and architecture (simple vs. complex features), with no further workup or follow-up needed for asymptomatic simple cysts. 1
Initial Diagnostic Approach
First-Line Imaging: Ultrasound
Ultrasound should be your initial diagnostic tool for multiple hepatic cysts 1. On ultrasound, look for:
- Anechoic content with posterior acoustic enhancement
- Thin, smooth walls with sharp borders
- Round or oval shape
The sensitivity and specificity of ultrasound for cystic liver lesions is approximately 90%, and it offers the advantages of wide availability, low cost, and no radiation exposure 1.
Critical Characterization Elements
When evaluating multiple hepatic cysts, document two key features 1:
- Number of lesions: Solitary vs. multiple (>10 cysts suggests polycystic liver disease)
- Architecture: Simple vs. complex
Simple cysts are characterized by:
- Homogeneous fluid content
- No septations, calcifications, or mural nodularity
- No wall thickening or enhancement
- No debris or fluid levels
Complex features that require further evaluation include:
- Septations or calcifications
- Mural thickening or nodularity
- Debris-containing fluid
- Hemorrhagic or proteinaceous contents
- Wall enhancement
- Associated bile duct dilatation
When to Advance Beyond Ultrasound
For Complex Features
If ultrasound reveals complex features, proceed immediately to MRI or CT for further characterization 1. This is a strong recommendation with 100% consensus because complex cysts require differentiation from:
- Mucinous cystic neoplasms
- Cystadenocarcinoma
- Hydatid cysts
- Cystic metastases
- Infected or hemorrhagic cysts
MRI Protocol for Complex Cases
When MRI is indicated, ensure the protocol includes 1:
- Heavily T2-weighted sequences (half-Fourier single-shot turbo spin echo)
- T1-weighted sequences
- Contrast-enhanced sequences
- MR cholangiography (particularly useful for biliary hamartomas)
MRI is superior to CT for detecting small cysts and assessing cyst contents (hemorrhagic vs. proteinaceous), and should be preferred over CT, especially in patients with renal insufficiency 1.
For Polycystic Liver Disease (>10 cysts)
If you identify >10 hepatic cysts, this defines polycystic liver disease 1. In asymptomatic patients:
- No additional imaging is required beyond the initial ultrasound
- No routine follow-up imaging is indicated 1
If symptoms develop or you need to assess for complications, use MRI or CT to evaluate:
- Distribution of cysts within liver parenchyma
- Relationship to hepatic vasculature
- Hepatic or portal vein compression
- Volume of non-affected liver parenchyma
Specific Differential Diagnoses to Consider
Biliary Hamartomas
If you see multiple small cystic lesions with a "starry sky" appearance, consider biliary hamartomas. Confirm with MRI using heavily T2-weighted sequences and MR cholangiography to demonstrate no communication with the biliary tree 1. These appear as:
- Multiple small lesions predominantly subcapsular and periportal
- Irregular shape with well-defined margins
- Hypointense on T1, markedly hyperintense on T2
Peribiliary Cysts
These are characterized by:
- Perihilar distribution on both sides of bile ducts
- Small size (<1 cm)
- Often associated with portal hypertension and cirrhosis
Caroli Disease
Look for segmental intrahepatic saccular or fusiform cystic areas with the "central dot sign" (fibrovascular bundles within dilated ducts). MR cholangiopancreatography provides optimal visualization 1.
Laboratory Testing
Tumor markers (CEA and CA19-9) in blood or cyst fluid cannot reliably discriminate between simple hepatic cysts and mucinous cystic neoplasms 1. This is a strong recommendation with 100% consensus, so do not rely on these markers for diagnosis.
If cyst aspiration is performed for suspected infection or to differentiate from neoplasm, TAG-72 in cyst fluid may help distinguish simple cysts from mucinous cystic neoplasms, though this is a weak recommendation 1.
Critical Management Pitfalls
Do NOT Follow Asymptomatic Simple Cysts
It is strongly recommended NOT to follow asymptomatic patients with simple hepatic cysts, biliary hamartomas, or peribiliary cysts 1. This recommendation has 96% consensus. Simple cysts follow an indolent course, and routine surveillance provides no benefit and exposes patients to unnecessary radiation and healthcare costs.
When Symptoms Develop
If patients become symptomatic, use ultrasound first to assess for:
- Cyst enlargement
- Complications (hemorrhage, infection)
- Compression of adjacent structures
- Bile duct compression (look for peripheral bile duct dilatation with centrally located cysts in segment 4)
Avoid Routine Post-Treatment Imaging
After aspiration sclerotherapy or surgical procedures, routine follow-up imaging is not recommended 1. Treatment success is defined by symptom relief, not volume reduction. This has 92% consensus.
Summary Algorithm
- Start with ultrasound for all patients with suspected multiple hepatic cysts
- Characterize by number and architecture (simple vs. complex)
- If simple cysts and asymptomatic: No further workup, no follow-up
- If complex features present: Advance to MRI (preferred) or CT with contrast
- If >10 cysts (PLD) and asymptomatic: No additional imaging needed
- If symptoms develop: Ultrasound first to assess complications
- Do not use tumor markers for routine differentiation
- Do not perform routine surveillance of asymptomatic lesions
This algorithmic approach prioritizes the 2022 EASL Clinical Practice Guidelines 1, which represent the most recent and authoritative guidance on cystic liver disease management.